TrademarkDir
OVIVA THERAPEUTICS
DEAD

Serial Number

90634639

Owner

Cambrian BioPharma, Inc.

Attorney

Matthew D. Delaney

Filing Date

Apr 9, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

OVIVA THERAPEUTICS Trademark

Serial Number: 90634639

OVIVA THERAPEUTICS is a trademark filed by Cambrian BioPharma, Inc. on April 9, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Cambrian BioPharma, Inc. (18 trademarks)

#66643
New York, NY 10003

Entity Type: 03

Trademark Details

Filing Date

April 9, 2021

Registration Date

Not Registered

Published for Opposition

November 2, 2021

Goods & Services

Pharmaceutical preparations for the prevention of ovarian disfunction; Pharmaceutical preparations for the prevention of infertility; Pharmaceutical preparations for the prevention of polycystic ovary syndrome; Pharmaceutical preparations for the treatment of ovarian disfunction; Pharmaceutical preparations for the treatment of oncofertoprotection; Pharmaceutical preparations for the treatment of infertility; Pharmaceutical preparations for the treatment of polycystic ovary syndrome; Pharmaceutical preparations for the treatment of reproductive disease; Pharmaceutical preparations for the treatment of neurodegenerative disease; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for evaluating ovarian function; Pharmaceutical preparations for the preservation of ovarian function; Pharmaceutical preparations for the improvement of ovarian function; Pharmaceutical preparations for supporting sex reassignment; Pharmaceutical preparations for contraception; Pharmaceutical preparations for treating indications of reproductive health

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 7, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 7, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
SOU EXTENSION 5 GRANTED
Jun 4, 2024 EX5G
SOU EXTENSION 5 FILED
Jun 4, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Jun 4, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 29, 2023 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 29, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 29, 2023 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 29, 2023 EXRA
SOU EXTENSION 4 GRANTED
Nov 27, 2023 EX4G
SOU EXTENSION 4 FILED
Nov 27, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 27, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 28, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jun 26, 2023 EX3G
SOU EXTENSION 3 FILED
Jun 26, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 26, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 21, 2022 EXRA
SOU EXTENSION 2 GRANTED
Dec 19, 2022 EX2G
SOU EXTENSION 2 FILED
Dec 19, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 19, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 23, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jun 21, 2022 EX1G
SOU EXTENSION 1 FILED
Jun 21, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 21, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 28, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 2, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 2, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 13, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 28, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 28, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 28, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 28, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 28, 2021 CNEA
ASSIGNED TO EXAMINER
Sep 28, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 17, 2021 NWOS
NEW APPLICATION ENTERED
Apr 13, 2021 NWAP

Related Trademarks

More from this Owner

TELOVANCE

TELOVANCE

TELOVANCE

TELOVANCE

AMPLIFIER TX

AMPLIFIER TX

AMPLIFIER THERAPEUTICS

AMPLIFIER THERAPEUTICS

AMPLIFIER

AMPLIFIER

ISTERIAN

ISTERIAN